Inhibikase Therapeutics (IKT) Stock Chart & Stock Price History $2.03 -0.05 (-2.40%) Closing price 04:00 PM EasternExtended Trading$2.01 -0.02 (-0.99%) As of 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock Inhibikase Therapeutics Stock Price Performance The Inhibikase Therapeutics (IKT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 12.15%, with a year-to-date return of -37.54%. In the past month, the stock has decreased 10.18%, reflecting recent market activity. As of the latest close, Inhibikase Therapeutics traded at $2.08 with a market cap of $154.63 million and volume of 93,803 shares. Receive IKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+14.69%1 Month Performance-10.18%3 Month Performance-11.74%Year-To-Date Performance-37.54%1 Year Performance+12.15% IKT Stock Chart for Friday, May, 30, 2025 IKT Chart by TradingView Inhibikase Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/30/2025$2.08$2.03-2.40%$2.16$1.9567,720 shs$150.91 million05/29/2025$2.04$2.08+1.96%$2.13$2.0493,803 shs$154.63 million05/28/2025$1.77$2.04+15.25%$2.12$1.76168,057 shs$151.66 million05/27/2025$1.77$1.77$1.94$1.70238,102 shs$131.59 million05/26/2025$1.77$1.77$1.93$1.75148,858 shs$131.59 million05/23/2025$1.84$1.77-3.80%$1.93$1.75148,858 shs$131.59 million05/22/2025$1.97$1.84-6.60%$2.02$1.83132,122 shs$136.79 million05/21/2025$1.99$1.97-1.01%$2.12$1.9090,400 shs$146.45 million05/20/2025$1.87$1.99+6.42%$1.99$1.8198,406 shs$147.94 million05/19/2025$2.01$1.87-6.97%$1.98$1.80120,330 shs$139.02 million Get the Latest News and Ratings for IKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/16/2025$2.03$2.01-0.99%$2.07$1.96118,059 shs$149.43 million05/15/2025$2.12$2.03-4.25%$2.11$1.9590,010 shs$150.91 million05/14/2025$2.23$2.12-4.93%$2.27$2.1289,490 shs$157.61 million05/13/2025$2.19$2.23+1.83%$2.26$2.01154,756 shs$165.78 million05/12/2025$2.00$2.19+9.50%$2.22$2.03161,439 shs$162.81 million05/09/2025$2.11$2.00-5.17%$2.09$1.94109,431 shs$148.68 million05/08/2025$1.84$2.11+14.62%$2.13$1.82135,135 shs$156.79 million05/07/2025$1.94$1.84-5.15%$1.94$1.78140,942 shs$136.79 million05/06/2025$2.09$1.94-7.18%$2.09$1.94131,358 shs$144.22 million05/05/2025$2.25$2.09-7.11%$2.30$2.0865,194 shs$155.38 million05/02/2025$2.24$2.25+0.45%$2.37$2.20116,487 shs$167.27 million05/01/2025$2.26$2.24-0.88%$2.31$2.2149,845 shs$166.53 million04/30/2025$2.25$2.26+0.44%$2.30$2.16131,592 shs$168.01 million04/29/2025$2.20$2.25+2.27%$2.26$2.13131,460 shs$167.27 million Related Companies OPT Stock Price Chart VALN Stock Price Chart STOK Stock Price Chart BCAX Stock Price Chart RLAY Stock Price Chart TYRA Stock Price Chart UPB Stock Price Chart KURA Stock Price Chart RGNX Stock Price Chart ARVN Stock Price Chart Receive IKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:IKT) was last updated on 5/30/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredHISTORIC Gold Move Sends Flashing Red Signal To 401K SaversHistorically, when panic hits Wall Street, investors rush to raise cash to cover their leveraged positions be ...Colonial Metals | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibikase Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibikase Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IKT Stock Free IKT Stock Alerts